KRAS-mutant colon cancer cells respond to combined treatment of ABT263 and axitinib.

Name: KRAS-mutant colon cancer cells respond to combined treatment of ABT263 and axitinib.
Author: Wang, Guihua

KRAS-mutant colon cancer cells respond to combined treatment of ABT263 and axitinib. — المؤلف: Wang, Guihua — Bioscience reports 20200220

المؤلف: Wang, Guihua
النشر: Bioscience reports 20200220
الموضوعات: Aniline Compounds؛ Animals؛ Antineoplastic Combined Chemotherapy Protocols؛ Apoptosis؛ Axitinib؛ Cell Line, Tumor؛ Colonic Neoplasms؛ Drug Synergism